nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A BRAF new world
|
Frisone, Daniele |
|
|
152 |
C |
p. |
artikel |
2 |
Anticoagulants for the treatment of venous thromboembolism in patients with cancer: A comprehensive systematic review, pairwise and network meta-analysis
|
Sidahmed, Shima |
|
|
152 |
C |
p. |
artikel |
3 |
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives
|
Leone, Gianmarco |
|
|
152 |
C |
p. |
artikel |
4 |
CD47: the next checkpoint target for cancer immunotherapy
|
Feng, Ridong |
|
|
152 |
C |
p. |
artikel |
5 |
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature
|
Di Lorenzo, Giuseppe |
|
|
152 |
C |
p. |
artikel |
6 |
Double immune checkpoint blockade in advanced NSCLC
|
Mariniello, Annapaola |
|
|
152 |
C |
p. |
artikel |
7 |
Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting – A systematic review and meta-analysis
|
Raghunath, Ajay |
|
|
152 |
C |
p. |
artikel |
8 |
Efficacy and safety of ibrutinib in diffuse large B-cell lymphoma: A single-arm meta-analysis
|
Hou, Kelu |
|
|
152 |
C |
p. |
artikel |
9 |
Immunotherapy as a second-line or later treatment modality for advanced non-small cell lung cancer: A review of safety and efficacy
|
Geraci, Emily |
|
|
152 |
C |
p. |
artikel |
10 |
Major and minor salivary gland tumours
|
Gatta, Gemma |
|
|
152 |
C |
p. |
artikel |
11 |
PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
|
Post, Cathalijne C.B. |
|
|
152 |
C |
p. |
artikel |
12 |
Patients with lung cancer undergoing immune checkpoint inhibitors: A meta-analysis of dermatological toxicities
|
Garrett, Náthali Felícia Mineiro dos Santos |
|
|
152 |
C |
p. |
artikel |
13 |
Radiomics in cervical cancer: Current applications and future potential
|
Ai, Yao |
|
|
152 |
C |
p. |
artikel |
14 |
Safety of dietary supplements use among patients with cancer: A systematic review
|
Zeng, Zhen |
|
|
152 |
C |
p. |
artikel |
15 |
Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice
|
Parmar, Ambica |
|
|
152 |
C |
p. |
artikel |
16 |
Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions
|
Tan, Yuxin |
|
|
152 |
C |
p. |
artikel |
17 |
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination
|
Roviello, Giandomenico |
|
|
152 |
C |
p. |
artikel |
18 |
The effect of exercise and motor interventions on physical activity and motor outcomes during and after medical intervention for children and adolescents with acute lymphoblastic leukemia: A systematic review
|
Coombs, Alison |
|
|
152 |
C |
p. |
artikel |
19 |
The Melanoma and Breast Cancer Association: An Overview of their ‘Second Primary Cancers’ and the Epidemiological, Genetic and Biological correlations
|
Jeyakumar, Arunan |
|
|
152 |
C |
p. |
artikel |
20 |
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions
|
Roviello, Giandomenico |
|
|
152 |
C |
p. |
artikel |
21 |
Updates in Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Lymphoma and Leukemia from the Annual Meeting of American Society of Hematology 2019
|
Bukhari, Ali |
|
|
152 |
C |
p. |
artikel |